TABLE 2.
Antibiotic | Cleaved-complex CC50 (μM) for enzymea:
|
|||
---|---|---|---|---|
Gyrase
|
Topoisomerase IV
|
|||
E. coli | S. aureus | E. coli | S. aureus | |
Ciprofloxacin | 0.2 | 11 | 0.6 | 0.5 |
Moxifloxacin | 0.6 | 2.5 | 0.5 | 0.8 |
NXL101 | >200 | >200 | 0.05 | >200 |
CC50 is the concentration of compound required to inhibit production of linear pBR322 by 50%. Each value is the average of at least two assays.